Advertisement Evotec names new CEO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Evotec names new CEO

Germany-based biotechnology company Evotec has appointed Werner Lanthaler as its new CEO.

In his previous position, Dr Lanthaler served as CFO of Intercell in Vienna, Austria, a biopharmaceutical company. In this role, Dr Lanthaler was also responsible for business development and marketing and sales.

Dr Lanthaler holds a doctorate in economics from Vienna University, earned his master’s degrees from Harvard University, and holds a degree in psychology.

Flemming Ornskov, chairman of the supervisory board at Evotec, said: “Dr Lanthaler is an ideal candidate to be CEO of Evotec at this juncture. His experience in building a highly successful company, his impressive track record in business and corporate development, and his strong sense for the creation of shareholder value are a perfect match with Evotec’s strategy to transform itself into a streamlined biopharmaceutical company.”